TFDA-2024-0031-V231
Major variation for application TFDA-2024-0031. Major variation: New Dosage Strength for Lorlatenilib — major revision
Variation Number
TFDA-2024-0031-V231
Type
Major
Application
Change
Status
Draft
Fee
€26,914
Submitted
2023-12-12
Approved
—
Description
Major variation: New Dosage Strength for Lorlatenilib — major revision